← Back to Report Home
Section 06

Outlook

Investment Analysis Growth Strategy | IPO Assessment | Key Risks | Investment View
50
Sneakrz Target
Stores by 2029
16%
Revenue CAGR
FY23-25 growth
23%
EBITDA Margin
Strong profitability
NSE SME
IPO Platform
Fresh issue

Investment Outlook

Brandman Retail presents an interesting opportunity in India's growing premium footwear market. The company has demonstrated strong financial performance with 153% PAT growth (FY25) and healthy 23% EBITDA margins. The Sneakrz expansion strategy (targeting 50 stores by 2029) provides a clear growth path. However, investors should note the significant concentration risk (72% revenue from New Balance) and non-exclusive distribution agreements. The NSE SME IPO offers exposure to premium footwear retail at an early stage.

Industry Outlook

India Apparel & Footwear Market

$100B (Current) $160B (2028)
8-9% CAGR
Organised Retail Share (Current)
~30%
Organised Retail Share (2028)
40-45%

Online channels will contribute a rising share of sales, but physical stores will remain central to discovery and experience.

Structural Drivers

🏙️
Tier-II/III Expansion
Cluster-based rollouts into emerging cities
💎
Premiumisation
Trade-up across apparel & footwear
🔄
Omnichannel Models
Integrating offline & online channels
📋
Retail Formalisation
GST & regulatory enforcement
📱
Social Media Influence
Digital marketing driving trends

Emerging Trends

👟
Athleisure & Sneaker Culture

Expected to outpace traditional apparel categories as fitness and casual wear converge.

🌱
Sustainability

Growing consumer interest in eco-friendly and ethically sourced products.

🤖
Technology Integration

Wider adoption of AI, augmented reality, and data-driven personalisation.

🏬
Experiential Retail

Increasing emphasis on in-store experiences to complement online channels.

Source: Industry Reports

Growth Strategy

Sneakrz Expansion

Aggressive expansion of multi-brand Sneakrz stores from 2 currently to 50 stores by 2029. Each store offers multiple brands, reducing single-brand dependency.

2 → 50
Stores by 2029
25x
Store Growth

Brand Portfolio Diversification

Adding new brands to reduce New Balance dependency. On Running added in 2024; potentially more brands in pipeline to diversify revenue.

5
Current Brands
72%→50%
Target NB Share

Geographic Expansion

Expanding beyond metros to Tier 2/3 cities. Current presence in India; distribution agreements cover Sri Lanka, Nepal, and Maldives.

4
Countries
Tier 2/3
Expansion Focus

Digital & D2C Growth

Strengthening e-commerce presence through marketplaces (Amazon, Flipkart, Myntra) and company website to capture digital-native consumers.

15%
D2C/Online Share
Growing
Digital Channel

Key Investment Risks

Critical Risk: Brand Concentration

72% of revenue comes from New Balance. Loss or reduction of this distribution agreement would materially impact the business. The agreement is non-exclusive, meaning New Balance can appoint additional distributors.

1

Brand Dependency Risk

New Balance contributes 72% of revenue. Termination or non-renewal of distribution agreement would severely impact business.

2

Non-Exclusive Agreements

All brand partnerships are non-exclusive. Brands can appoint additional distributors or go direct-to-consumer.

3

Execution Risk

Ambitious Sneakrz expansion (2 to 50 stores) requires significant capital and operational capability. Execution delays possible.

4

Competition Intensity

Faces competition from Nike, Adidas (direct), Metro Brands (retail), and e-commerce platforms in premium footwear segment.

5

SME Liquidity Risk

NSE SME platform typically has lower trading volumes. Exit may be challenging for large positions.

Management Report Home
Disclaimer: This report is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. The views expressed are based on publicly available information. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.